CMV Infection in Transplant Recipients

Cytomegalovirus (CMV) infection is a serious condition and an important cause of morbidity and mortality in recipients of hematopoietic stem cell transplant (HSCT) and solid organ transplant (SOT). Controversy exists regarding the best method for CMV prevention. It is important for healthcare professionals working with transplant recipients to be aware of the advantages and limitations of the current strategies available for managing CMV infection and disease in this population.

To address the need for current education on CMV infection in transplant recipients, Robert Michael Educational Institute LLC (RMEI) and the Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing education virtual lecture for physicians, pharmacists, nurses, and other infectious disease specialists. This activity is supported by an educational grant from ViroPharma Incorporated.

Faculty for this virtual lecture include Michael J. Boeckh, MD, associate member of the Program of Infectious Diseases at Fred Hutchinson Cancer Research Center and associate professor at the University of Washington School of Medicine in Seattle; John R. Wingard, MD, professor and Price Chair of Medicine in the Department of Pediatrics and director of the Blood and Bone Marrow Transplant Program at the University of Florida Shands Cancer Center in Gainesville, Fla.; Raymund R. Razonable, MD, assistant professor of medicine at the Mayo Clinic College of Medicine in Rochester, Minn.; and Ajit P. Limaye, MD, associate professor of laboratory medicine and co-director of the Clinical Microbiology Laboratory and director of the Organ Transplant Infectious Diseases Program at the University of Washington Medical Center in Seattle.

Healthcare professionals can access the "CMV Infection in Transplant Recipients: Clinical Cases and Expert Opinion" virtual lecture at:

"Robert Michael Educational Institute LLC is committed to providing healthcare professionals with opportunities for quality, innovative, and convenient continuing medical education," says president and CEO, Robert M. Colleluori.

RMEI is a medical education company that specializes in independent, accredited, and nonaccredited education. The goal of all accredited RMEI educational offerings is to promote a spirit of lifelong learning and continuous professional development. RMEI works closely with medical experts to design activities that improve diagnosis and treatment. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.

Source: Robert Michael Educational Institute LLC